Müller V - Search Results

1

Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry.

Mandelkow T, Bady E, Lurati MCJ, Raedler JB, Müller JH, Huang Z, Vettorazzi E, Lennartz M, Clauditz TS, Lebok P, Steinhilper L, Woelber L, Sauter G, Berkes E, Bühler S, Paluchowski P, Heilenkötter U, Müller V, Schmalfeldt B, von der Assen A, Jacobsen F, Krech T, Krech RH, Simon R, Bernreuther C, Steurer S, Burandt E, Blessin NC. Mandelkow T, et al. Among authors: muller jh, muller v. Biomedicines. 2023 Nov 29;11(12):3175. doi: 10.3390/biomedicines11123175. Biomedicines. 2023. PMID: 38137396 Free PMC article.

2

Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases.

Choschzick M, Woelber L, Hess S, zu Eulenburg C, Schwarz J, Simon R, Mahner S, Jaenicke F, Müller V. Choschzick M, et al. Among authors: muller v. Virchows Arch. 2010 May;456(5):483-90. doi: 10.1007/s00428-010-0905-9. Epub 2010 Apr 1. Virchows Arch. 2010. PMID: 20358226

3

Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.

Kock L, Mahner S, Choschzick M, Eulenburg C, Milde-Langosch K, Schwarz J, Jaenicke F, Müller V, Woelber L. Kock L, et al. Among authors: muller v. Int J Gynecol Cancer. 2011 Jan;21(1):141-8. doi: 10.1097/IGC.0b013e318204c34f. Int J Gynecol Cancer. 2011. PMID: 21330838

4

Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer.

Choschzick M, Oosterwijk E, Müller V, Woelber L, Simon R, Moch H, Tennstedt P. Choschzick M, et al. Among authors: muller v. Virchows Arch. 2011 Aug;459(2):193-200. doi: 10.1007/s00428-011-1105-y. Epub 2011 Jun 21. Virchows Arch. 2011. PMID: 21691815

5

Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.

Ihnen M, Kress K, Kersten JF, Kilic E, Choschzick M, Zander H, Müller V, Mahner S, Jänicke F, Woelber L, Milde-Langosch K. Ihnen M, et al. Among authors: muller v. BMC Cancer. 2012 Apr 4;12:140. doi: 10.1186/1471-2407-12-140. BMC Cancer. 2012. PMID: 22475274 Free PMC article.

6

Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer.

Mathey S, Graeser MK, Zu Eulenburg C, Woelber L, Trillsch F, Jaenicke F, Müller V, Milde-Langosch K, Mahner S. Mathey S, et al. Among authors: muller v. Oncology. 2013;85(2):69-77. doi: 10.1159/000351032. Epub 2013 Jul 16. Oncology. 2013. PMID: 23860180

7

Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients.

Wikman H, Westphal L, Schmid F, Pollari S, Kropidlowski J, Sielaff-Frimpong B, Glatzel M, Matschke J, Westphal M, Iljin K, Huhtala H, Terracciano L, Kallioniemi A, Sauter G, Müller V, Witzel I, Lamszus K, Kemming D, Pantel K. Wikman H, et al. Among authors: muller v. Oncotarget. 2014 May 30;5(10):3076-87. doi: 10.18632/oncotarget.1832. Oncotarget. 2014. PMID: 24833255 Free PMC article.

8

Cyclin D1 gene amplification is highly homogeneous in breast cancer.

Burandt E, Grünert M, Lebeau A, Choschzick M, Quaas A, Jänicke F, Müller V, Scholz U, Bokemeyer C, Petersen C, Geist S, Paluchowski P, Wilke C, Heilenkötter U, Simon R, Sauter G, Wilczak W. Burandt E, et al. Among authors: muller v. Breast Cancer. 2016 Jan;23(1):111-119. doi: 10.1007/s12282-014-0538-y. Epub 2014 May 27. Breast Cancer. 2016. PMID: 24862872

9

Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.

Milde-Langosch K, Schütze D, Oliveira-Ferrer L, Wikman H, Müller V, Lebok P, Pantel K, Schröder C, Witzel I, Schumacher U. Milde-Langosch K, et al. Among authors: muller v. Breast Cancer Res Treat. 2015 Jun;151(3):515-28. doi: 10.1007/s10549-015-3425-0. Epub 2015 May 15. Breast Cancer Res Treat. 2015. PMID: 25975956

10

High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer.

Lebok P, Öztürk M, Heilenkötter U, Jaenicke F, Müller V, Paluchowski P, Geist S, Wilke C, Burandt E, Lebeau A, Wilczak W, Krech T, Simon R, Sauter G, Quaas A. Lebok P, et al. Among authors: muller v. Oncol Lett. 2016 Mar;11(3):1987-1994. doi: 10.3892/ol.2016.4206. Epub 2016 Feb 9. Oncol Lett. 2016. PMID: 26998111 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,643 results

Search Page

Filters